Blacktown Hospital’s Dr Dmitrii Shek has been recognised with the prestigious 2023 Australasian Gastro-Intestinal Trials Group (AGITG) Early Career Researcher Award, presented by Prof. Chris Karapetis in New Zealand.
The accolade, which celebrates outstanding contributions to medical research, was awarded to Dmitrii for his remarkable work within AGITG since joining in 2021.
Dmitrii’s PhD project ‘ICEMELT’ (titled after the study, ‘risk factors of Immune-ChEckpoint inhibitors MEdiated Liver, gastrointestinal, endocrine and skin Toxicity‘), an actively recruiting AGITG-endorsed study, has garnered attention for its potential impact on cancer immunotherapy.
Western Sydney Local Health District’s Professor Golo Ahlenstiel, Study Chair of ICEMELT, lauded Dmitrii’s accomplishments.
Within a very short period of time, Dmitrii has proven undoubtedly that he is an outstanding student and future leader in research.Professor Golo Ahlenstiel
Dmitrii has already published four papers during his PhD, with another accepted in the prestigious journal Genes & Diseases.
He presented preliminary data from the ICEMELT trial at the 2023 NSW Cancer Conference, where he received the Best PhD Oral Presentation Award, and has secured competitive grants totaling $300,000 for research funding between 2020 to 2023. His passion for medical research is deeply rooted in personal experience, having lost a loved one to cholangiocarcinoma, a gastrointestinal cancer.
“I feel truly grateful and honoured,” Dmitrii said.
I’m committed to advancing both medical understanding and patient well-being, partly because of my own personal experience. I’m also determined to actively engage in teaching and mentorship, fostering the growth of the next generation of professionals over the next five years.Dr Dmitrii Shek
“I would like to thank Western Sydney Local Health District, the AGITG, Western Sydney University, Maridulu Budyari Gumal SPHERE Group, Cancer Institute NSW and Professor Golo Ahlenstiel. Thank you so much.”